PERSPECTIVE THERAPEUTICS, INC. Current Liabilities
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Current Liabilities of $36.54 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-10
- 2026-06-30: Liabilities, Current $36.54M.
- 2026-03-31: Liabilities, Current $31.49M.
- 2025-12-31: Liabilities, Current $28.68M.
- 2025-09-30: Liabilities, Current $20.62M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $36.54M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $31.49M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $28.68M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $20.62M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $12.99M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $12.68M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $18.23M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $28.14M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $10.61M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $14.50M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $15.66M 10-K/A · filed 2025-03-28 | |
| 2023-09-30 | $8.12M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $8.59M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $7.19M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $3.12M 10-K · filed 2024-03-28 | $2.68M 10-KT · filed 2023-05-01 |
| 2022-09-30 | $4.00M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.27M 10-KT · filed 2023-05-01 | |
| 2022-03-31 | $1.96M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.84M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $1.80M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $1.80M 10-KT · filed 2023-05-01 | |
| 2021-03-31 | $1.92M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.33M 10-Q · filed 2021-02-09 | |
| 2020-09-30 | $1.52M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $1.57M 10-K · filed 2021-09-27 | |
| 2020-03-31 | $1.74M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $1.34M 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $1.67M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $1.12M 10-K · filed 2020-09-25 | |
| 2019-03-31 | $1.35M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $1.64M 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $1.64M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.83M 10-K · filed 2019-09-27 | |
| 2018-03-31 | $1.12M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $931.00K 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $1.07M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $1.11M 10-K · filed 2018-09-26 | |
| 2017-03-31 | $1.14M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $871.00K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $1.12M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $1.09M 10-K · filed 2017-09-28 | $1.09M 10-K · filed 2016-09-09 |
| 2016-03-31 | $1.21M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $1.08M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $931.38K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $1.09M 10-K · filed 2016-09-09 | |
| 2015-03-31 | $880.91K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $941.89K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $979.07K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $1.15M 10-K · filed 2015-09-14 | |
| 2014-03-31 | $1.02M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $847.28K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $969.90K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $792.87K 10-K · filed 2014-09-29 | |
| 2013-03-31 | $649.27K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $696.81K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $578.38K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $648.99K 10-K · filed 2013-09-30 | |
| 2012-03-31 | $626.11K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $760.87K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $918.43K 10-Q/A · filed 2011-12-13 | |
| 2011-06-30 | $774.20K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |